Top Wall Street analysts are bullish on the growth potential of these 3 stocks — SkimNews

Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- Morgan Stanley's Erin Wright reiterated a buy on UnitedHealth (UNH) with a $529 price target after the insurer beat Q3 2026 expectations and lifted its full-year adjusted EPS outlook to at least $20.50.
- UnitedHealth management views 2027 EPS consensus of $22.63 as too conservative, with Wright raising her 2027 EPS estimate to $23.24 from $22.54 and flagging an improving 2026 medical loss ratio to 87.4% from 88.1%.
- Guggenheim's Michael Morris raised his Meta Platforms (META) price target to $850 from $700, citing the Muse AI agent reaching 1.3 million daily active users in five weeks versus 300,000 in the first week.
- Meta's Muse AI agent adoption represents less than 0.05% of the company's 3.6 billion daily active users, a figure Morris said signals management will prioritize boosting usage over near-term monetization ahead of the Oct. 21 Q3 earnings call.
- Marvell Technology raised its total addressable market estimate to $400 billion by 2030 at its Investor Day, lifting its FY29 Custom revenue target to over $12 billion from more than $10 billion on strength in its XPU Attach business.
- Stifel analyst Tore Svanberg reiterated a buy on Marvell (MRVL) with a $370 price target, noting management secured supplier commitments ahead of Investor Day to support its five-year goals and a FY31 Custom revenue target of $30 billion.
Why it matters: The picks span three sectors with distinct growth theses: UnitedHealth's operational turnaround is now reflected in raised analyst estimates, Meta's AI monetization is just beginning with negligible current user penetration, and Marvell's supplier-backed commitments de-risk its aggressive ramp to a $30 billion FY31 Custom target. For long-term investors, the convergence of high-conviction analyst support across healthcare, social AI, and custom silicon signals where top-rated pros see durable growth through choppy markets.
Ask SkimNews



